Hologic (HOLX) shares undervalued - Needham & Company
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/29/2026
- Wall St indexes climb as US, Iran halt attacks; Comcast surges on spin-off plan
- Tech funds suffer record outflows as investors trim equity positions
- Comcast shares surge 23% on blockbuster plan to spin off NBCUniversal and Sky
- New leader board: Citi refreshes AI compute semiconductor picks
- Martin Marietta confirms $13.5B deal for Lhoist North America
- Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2
- Needham Starts NeoVolta (NEOV) at Buy
- Personalis, Inc. (PSNL) and Tempus (TEM) Expand Collaboration
- Strategy stock jumps 7% as firm shifts to active capital management
- TD Cowen: 'Sober View Suggests Structural Alcohol Risks Are Overblown'
Needham & Company Upgrades Hologic (HOLX) to Buy as COVID-related headwind will soon end
July 14, 2023 6:51 AM EDT(Updated - July 14, 2023 7:48 AM EDT)
Needham & Company analyst Mike Matson upgraded Hologic (NASDAQ: HOLX) from Hold to Buy with a price target of $95.00.
The analyst commented, "We are upgrading HOLX shares to Buy from Hold. We think the... More
